Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 164

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Cost-Effectiveness of Psychological and Pharmacological Interventions for Generalized Anxiety Disorder and Panic Disorder

Heuzenroeder, Louise, Donnelly, Marie, Haby, Michelle M., Mihalopoulos, Cathrine, Rossell, Ruth, Carter, Rob, Andrews, Gavin, Vos, Theo·2004·Australian & New Zealand Journal of Psychiatry

Abstract

Objective: To assess from a health sector perspective the incremental cost-effectiveness of interventions for generalized anxiety disorder (cognitive behavioural therapy [CBT] and serotonin and noradrenaline reuptake inhibitors [SNRIs]) and panic disorder (CBT, selective serotonin reuptake inhibitors [SSRIs] and tricyclic antidepressants [TCAs]). Method: The health benefit is measured as a reduction in disability-adjusted life years (DALYs), based on effect size calculations from meta-analyses of randomised controlled trials. An assessment on second stage filters (‘equity’, ‘strength of evidence’, ‘feasibility’ and ‘acceptability to stakeholders’) is also undertaken to incorporate additional factors that impact on resource allocation decisions. Costs and benefits are calculated for a period of one year for the eligible population (prevalent cases of generalized anxiety disorder/panic disorder identified in the National Survey of Mental Health and Wellbeing, extrapolated to the Australian population in the year 2000 for those aged 18 years and older). Simulation modelling techniques are used to present 95% uncertainty intervals (UI) around the incremental cost-effectiveness ratios (ICERs). Results: Compared to current practice, CBT by a psychologist on a public salary is the most cost-effective intervention for both generalized anxiety disorder (A$6900/DALY saved; 95% UI A$4000 to A$12 000) and panic disorder (A$6800/DALY saved; 95% UI A$2900 to A$15 000). Cognitive behavioural therapy results in a greater total health benefit than the drug interventions for both anxiety disorders, although equity and feasibility concerns for CBT interventions are also greater. Conclusions: Cognitive behavioural therapy is the most effective and cost-effective intervention for generalized anxiety disorder and panic disorder. However, its implementation would require policy change to enable more widespread access to a sufficient number of trained therapists for the treatment of anxiety disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/j.1440-1614.2004.01423.x

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 35

  1. 1. Mathers C D, Vos T, Stevenson C. The burden of disease and injury in Australia. Australian Institute of Health and Welfare, Canberra 1999.
  2. 10.3810/pgm.1999.05.1.740 · doi:10.3810/pgm.1999.05.1.740
  3. 3. World Health Organisation. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. GenevaSwitzerland 1992.
  4. 4. Australian Bureau of Statistics. Mental health and wellbeing: profile of adults, Australia 1997. Australian Bureau of Statistics, Canberra 1998.
  5. 5. Therapeutic Guidelines Limited. Therapeutic guidelines: psychotropic 4th edn. Therapeutic Guidelines Limited, Melbourne 2000.
  6. 7. Kapczinski F, Schmitt R, Lima M. The use of antidepressants for generalized anxiety disorder. The Cochrane Library,: Issue 2. Update Software, Oxford.
  7. 8. Sheehan D V. Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative data. Journal of Clinical Psychiatry 2001; 62(Suppl. 19)26–31.
  8. 10.1001/jama.283.23.3082 · DOI · Paper page
  9. 10.1176/appi.ajp.157.6.968 · DOI · Paper page
  10. 10.4088/JCP.v62n07a04 · DOI
  11. 12. Pollack M H Zaninelli R Goddard A. 2001; 62: 350–357. · DOI · Paper page
  12. 10.1111/j.1600-0447.1997.tb09660.x · DOI · Paper page
  13. 10.1097/00004714-199804000-00006 · DOI
  14. 15. Caswell A. MIMS, Caswell A. MediMedia Australia, Sydney 2001.
  15. 10.1080/j.1440-1614.2003.01254.x · DOI
  16. 17. Haby M, Carter R, Mihalopoulos C, Magnus A, Andrews G, Vos T. Assessing Cost-Effectiveness –Mental Health: introduction to the study and methods. Australian and New Zealand Journal of Psychiatry 2004; 38: 569–578.
  17. 10.4088/JCP.v60n0805 · DOI · Paper page
  18. 20. Australian Bureau of Statistics. Census data 2000: population by age and sex, Australian states and territories. Australian Bureau of Statistics, Canberra 2001, Time series spreadsheet, 32010.0: Table 9.
  19. 10.1111/j.1600-0447.1991.tb03176.x · DOI · Paper page
  20. 22. Keller M. The long-term clinical course of generalised anxiety disorder. Journal of Clinical Psychiatry 2002; 63(Suppl. 8)11–16.
  21. 10.1192/bjp.176.6.544 · DOI · Paper page
  22. 10.1023/B:QURE.0000037482.92757.82 · DOI
  23. 27. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV) 4th edn. American Psychiatric Press, Washington, DC 1994.
  24. 10.1192/bjp.165.3.315 · DOI · Paper page
  25. 10.1017/S014134730001689X · DOI
  26. 10.1093/oso/9780192631770.001.0001 · DOI · Paper page
  27. 35. Palisade Corporation. @RISK [computer program] Risk Analysis Add-in for Microsoft Excel. Palisade Corporation, Newfield, NY 2001, Version 4.
  28. 10.1037/0022-006X.68.4.556 · doi:10.1037/0022-006x.68.4.556 · Paper page
  29. 10.1097/00004850-200015020-00006 · DOI
  30. 10.1192/bjp.174.3.213 · DOI
  31. 10.1034/j.1600-0447.2001.00263.x · DOI · Paper page
  32. 10.1111/j.1600-0447.1999.tb05385.x · DOI
  33. 10.1192/S0007125000293513 · DOI
  34. 43. Perry S. Combining antidepressants and psychotherapy: rationale and strategies. Journal of Clinical Psychiatry 1990; 51(Suppl.)16–20.
  35. 10.1176/ajp.147.1.51 · DOI · Paper page

Cited by

See all 164

Metadata

Authors
Heuzenroeder, L., Donnelly, M., Haby, M. M., Mihalopoulos, C., Rossell, R., Carter, R., Andrews, G., & Vos, T.
Venue
Australian & New Zealand Journal of Psychiatry
Published
2004-08
Volume
38
Issue
8
Pages
602-612
ISSN
  • 0004-8674 (ISSN-L)
  • 1440-1614
OpenAlex
W2102630283
Cited by
164
References
8
FWCI
17.38
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cost-Effectiveness of Psychological and Pharmacological Interventions for Generalized Anxiety Disorder and Panic Disorder. https://app.cochat.ai/papers/10.1080/j.1440-1614.2004.01423.x
The paper
Heuzenroeder, L., Donnelly, M., Haby, M. M., Mihalopoulos, C., Rossell, R., Carter, R., Andrews, G., & Vos, T. (2004). Cost-Effectiveness of Psychological and Pharmacological Interventions for Generalized Anxiety Disorder and Panic Disorder. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1080/j.1440-1614.2004.01423.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.